Literature DB >> 18436240

Zinc binding catalytic domain of human tankyrase 1.

Lari Lehtiö1, Ruairi Collins, Susanne van den Berg, Andreas Johansson, Lars-Göran Dahlgren, Martin Hammarström, Thomas Helleday, Lovisa Holmberg-Schiavone, Tobias Karlberg, Johan Weigelt.   

Abstract

Tankyrases are recently discovered proteins implicated in many important functions in the cell including telomere homeostasis and mitosis. Tankyrase modulates the activity of target proteins through poly(ADP-ribosyl)ation, and here we report the structure of the catalytic poly(ADP-ribose) polymerase (PARP) domain of human tankyrase 1. This is the first structure of a PARP domain from the tankyrase subfamily. The present structure reveals that tankyrases contain a short zinc-binding motif, which has not been predicted. Tankyrase activity contributes to telomere elongation observed in various cancer cells and tankyrase inhibition has been suggested as a potential route for cancer therapy. In comparison with other PARPs, significant structural differences are observed in the regions lining the substrate-binding site of tankyrase 1. These findings will be of great value to facilitate structure-based design of selective PARP inhibitors, in general, and tankyrase inhibitors, in particular.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18436240     DOI: 10.1016/j.jmb.2008.03.058

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  21 in total

1.  Zinc deficiency or excess within the physiological range increases genome instability and cytotoxicity, respectively, in human oral keratinocyte cells.

Authors:  Razinah Sharif; Philip Thomas; Peter Zalewski; Michael Fenech
Journal:  Genes Nutr       Date:  2011-09-21       Impact factor: 5.523

2.  Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells.

Authors:  Ozlem Kulak; Hua Chen; Brody Holohan; Xiaofeng Wu; Huawei He; Dominika Borek; Zbyszek Otwinowski; Kiyoshi Yamaguchi; Lauren A Garofalo; Zhiqiang Ma; Woodring Wright; Chuo Chen; Jerry W Shay; Xuewu Zhang; Lawrence Lum
Journal:  Mol Cell Biol       Date:  2015-05-04       Impact factor: 4.272

Review 3.  PARP inhibition: PARP1 and beyond.

Authors:  Michèle Rouleau; Anand Patel; Michael J Hendzel; Scott H Kaufmann; Guy G Poirier
Journal:  Nat Rev Cancer       Date:  2010-03-04       Impact factor: 60.716

4.  Pyrimidinone nicotinamide mimetics as selective tankyrase and wnt pathway inhibitors suitable for in vivo pharmacology.

Authors:  Jeffrey W Johannes; Lynsie Almeida; Bernard Barlaam; P Ann Boriack-Sjodin; Robert Casella; Rosemary A Croft; Allan P Dishington; Lakshmaiah Gingipalli; Chungang Gu; Janet L Hawkins; Jane L Holmes; Tina Howard; Jian Huang; Stephanos Ioannidis; Steven Kazmirski; Michelle L Lamb; Thomas M McGuire; Jane E Moore; Derek Ogg; Anil Patel; Kurt G Pike; Timothy Pontz; Graeme R Robb; Nancy Su; Haiyun Wang; Xiaoyun Wu; Hai-Jun Zhang; Yue Zhang; Xiaolan Zheng; Tao Wang
Journal:  ACS Med Chem Lett       Date:  2015-01-13       Impact factor: 4.345

5.  Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors.

Authors:  Elisabet Wahlberg; Tobias Karlberg; Ekaterina Kouznetsova; Natalia Markova; Antonio Macchiarulo; Ann-Gerd Thorsell; Ewa Pol; Åsa Frostell; Torun Ekblad; Delal Öncü; Björn Kull; Graeme Michael Robertson; Roberto Pellicciari; Herwig Schüler; Johan Weigelt
Journal:  Nat Biotechnol       Date:  2012-02-19       Impact factor: 54.908

6.  Structure of human tankyrase 1 in complex with small-molecule inhibitors PJ34 and XAV939.

Authors:  Christina A Kirby; Atwood Cheung; Aleem Fazal; Michael D Shultz; Travis Stams
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-01-21

7.  Unravelling the Structural Mechanism of Action of 5-methyl-5-[4-(4-oxo-3H-quinazolin-2-yl)phenyl]imidazolidine-2,4-dione in Dual-Targeting Tankyrase 1 and 2: A Novel Avenue in Cancer Therapy.

Authors:  Xylia Q Peters; Clement Agoni; Mahmoud E S Soliman
Journal:  Cell Biochem Biophys       Date:  2022-05-30       Impact factor: 2.989

8.  Evolutionary history of the poly(ADP-ribose) polymerase gene family in eukaryotes.

Authors:  Matteo Citarelli; Sachin Teotia; Rebecca S Lamb
Journal:  BMC Evol Biol       Date:  2010-10-13       Impact factor: 3.260

9.  Novel binding mode of a potent and selective tankyrase inhibitor.

Authors:  Hakan Gunaydin; Yan Gu; Xin Huang
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

Review 10.  Structural biology of the writers, readers, and erasers in mono- and poly(ADP-ribose) mediated signaling.

Authors:  Tobias Karlberg; Marie-France Langelier; John M Pascal; Herwig Schüler
Journal:  Mol Aspects Med       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.